Company Filing History:
Years Active: 2008-2010
Title: The Innovations of Daniel A Ruppar
Introduction
Daniel A Ruppar is a notable inventor based in San Antonio, TX (US). He has made significant contributions to the field of pharmaceuticals, particularly in the area of thrombopoietin activity modulation. With a total of 2 patents to his name, Ruppar's work is recognized for its potential impact on medical treatments.
Latest Patents
Ruppar's latest patents include innovative compounds designed to modulate thrombopoietin activity. These patents disclose compounds of Formula (I), (II), and (III), along with pharmaceutical compositions that comprise these compounds. The methods outlined in his patents focus on modulating the activity of a thrombopoietin receptor, identifying compounds as thrombopoietin receptor modulators, and treating diseases by administering these compounds to patients in need.
Career Highlights
Ruppar is currently associated with Ligand Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work is pivotal in exploring new therapeutic avenues that could benefit patients suffering from various conditions related to thrombopoietin activity.
Collaborations
Some of Ruppar's notable coworkers include Jyun-Hung Chen and E Adam Kallel. Their collaborative efforts contribute to the innovative research environment at Ligand Pharmaceuticals, Inc.
Conclusion
Daniel A Ruppar's contributions to the field of pharmaceuticals through his patents and collaborative work highlight his role as an influential inventor. His research on thrombopoietin activity modulation holds promise for future medical advancements.